AVDL logo

Avadel Pharmaceuticals plc (AVDL) EBITDA

Annual EBITDA:

-$35.57M+$113.56M(+76.15%)
December 31, 2024

Summary

  • As of today, AVDL annual EBITDA is -$35.57 million, with the most recent change of +$113.56 million (+76.15%) on December 31, 2024.
  • During the last 3 years, AVDL annual EBITDA has risen by +$46.82 million (+56.83%).
  • AVDL annual EBITDA is now -136.07% below its all-time high of $98.59 million, reached on December 31, 2017.

Performance

AVDL EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLincome statement metrics

Quarterly EBITDA:

$3.05M-$6.90M(-69.33%)
September 30, 2025

Summary

  • As of today, AVDL quarterly EBITDA is $3.05 million, with the most recent change of -$6.90 million (-69.33%) on September 30, 2025.
  • Over the past year, AVDL quarterly EBITDA has increased by +$2.34 million (+331.07%).
  • AVDL quarterly EBITDA is now -91.01% below its all-time high of $33.96 million, reached on June 30, 2015.

Performance

AVDL Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLincome statement metrics

TTM EBITDA:

$8.20M+$2.34M(+40.03%)
September 30, 2025

Summary

  • As of today, AVDL TTM EBITDA is $8.20 million, with the most recent change of +$2.34 million (+40.03%) on September 30, 2025.
  • Over the past year, AVDL TTM EBITDA has increased by +$70.23 million (+113.22%).
  • AVDL TTM EBITDA is now -92.88% below its all-time high of $115.08 million, reached on December 31, 2015.

Performance

AVDL TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

AVDL EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+76.2%+331.1%+113.2%
3Y3 Years+56.8%+118.3%+108.7%
5Y5 Years-50.6%+122.3%+130.0%

AVDL EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+76.2%-69.3%+106.2%at high+106.0%
5Y5-Year-470.4%+76.2%-69.3%+106.2%at high+106.0%
All-TimeAll-Time-136.1%+76.2%-91.0%+106.2%-92.9%+106.0%

AVDL EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$3.05M(-69.3%)
$8.20M(+40.0%)
Jun 2025
-
$9.95M(+557.4%)
$5.86M(+135.7%)
Mar 2025
-
-$2.18M(+17.2%)
-$16.40M(+58.7%)
Dec 2024
-$35.57M(+76.1%)
-$2.63M(-471.3%)
-$39.72M(+36.0%)
Sep 2024
-
$708.00K(+105.8%)
-$62.03M(+36.2%)
Jun 2024
-
-$12.30M(+51.7%)
-$97.25M(+27.4%)
Mar 2024
-
-$25.49M(-2.2%)
-$133.89M(+1.6%)
Dec 2023
-$149.13M(-52.8%)
-$24.94M(+27.7%)
-$136.10M(-1.7%)
Sep 2023
-
-$34.52M(+29.5%)
-$133.79M(-15.4%)
Jun 2023
-
-$48.94M(-76.6%)
-$115.91M(-24.5%)
Mar 2023
-
-$27.71M(-22.4%)
-$93.07M(+0.7%)
Dec 2022
-$97.60M(-18.5%)
-$22.63M(-36.1%)
-$93.72M(+0.3%)
Sep 2022
-
-$16.63M(+36.3%)
-$94.03M(+8.6%)
Jun 2022
-
-$26.10M(+8.0%)
-$102.87M(-4.4%)
Mar 2022
-
-$28.37M(-23.7%)
-$98.50M(-16.2%)
Dec 2021
-$82.39M(-958.0%)
-$22.93M(+9.9%)
-$84.78M(-12.0%)
Sep 2021
-
-$25.47M(-17.2%)
-$75.72M(-18.5%)
Jun 2021
-
-$21.74M(-48.4%)
-$63.92M(-38.3%)
Mar 2021
-
-$14.65M(-5.6%)
-$46.21M(-32.1%)
Dec 2020
$9.60M(+140.7%)
-$13.87M(-1.4%)
-$34.97M(-27.9%)
Sep 2020
-
-$13.67M(-239.2%)
-$27.35M(-85.9%)
Jun 2020
-
-$4.03M(-18.4%)
-$14.71M(-10.5%)
Mar 2020
-
-$3.40M(+45.5%)
-$13.31M(+7.2%)
Dec 2019
-$23.61M(+75.2%)
-$6.25M(-507.9%)
-$14.34M(+30.3%)
Sep 2019
-
-$1.03M(+60.9%)
-$20.57M(+47.1%)
Jun 2019
-
-$2.63M(+40.8%)
-$38.87M(+22.3%)
Mar 2019
-
-$4.44M(+64.4%)
-$50.04M(+5.8%)
Dec 2018
-$95.14M(-196.5%)
-$12.48M(+35.5%)
-$53.12M(-17.1%)
Sep 2018
-
-$19.33M(-40.1%)
-$45.38M(-386.2%)
Jun 2018
-
-$13.80M(-83.5%)
-$9.33M(-134.3%)
Mar 2018
-
-$7.52M(-58.9%)
$27.20M(-57.9%)
Dec 2017
$98.59M(+1619.5%)
-$4.73M(-128.3%)
$64.58M(-24.6%)
Sep 2017
-
$16.72M(-26.5%)
$85.61M(+10.7%)
Jun 2017
-
$22.74M(-23.8%)
$77.36M(+9.1%)
Mar 2017
-
$29.86M(+83.3%)
$70.91M(+20.7%)
Dec 2016
$5.73M(-93.7%)
$16.29M(+92.3%)
$58.75M(-17.7%)
Sep 2016
-
$8.47M(-48.0%)
$71.41M(-25.9%)
Jun 2016
-
$16.28M(-8.0%)
$96.38M(-15.5%)
Mar 2016
-
$17.70M(-38.9%)
$114.06M(-0.9%)
Dec 2015
$90.84M(+229.3%)
$28.95M(-13.4%)
$115.08M(+46.5%)
Sep 2015
-
$33.44M(-1.5%)
$78.54M(+98.5%)
Jun 2015
-
$33.96M(+81.3%)
$39.57M(+2201.7%)
Mar 2015
-
$18.73M(+346.6%)
$1.72M(+108.6%)
Dec 2014
-$70.24M(-40.2%)
-$7.59M(-37.3%)
-$20.03M(+10.5%)
Sep 2014
-
-$5.53M(-42.3%)
-$22.38M(-2.4%)
Jun 2014
-
-$3.89M(-28.6%)
-$21.85M(+4.8%)
Mar 2014
-
-$3.02M(+69.6%)
-$22.95M(+11.7%)
Dec 2013
-$50.10M(-712.2%)
-$9.94M(-98.9%)
-$25.98M(-62.0%)
Sep 2013
-
-$5.00M(-0.2%)
-$16.04M(-45.3%)
Jun 2013
-
-$4.99M(+17.6%)
-$11.04M(+2.9%)
Mar 2013
-
-$6.05M(-13.7%)
-$11.38M(-1130.4%)
Dec 2012
-$6.17M(-19.5%)
-
-
Jun 2012
-
-$5.32M(-76.4%)
$1.10M(-70.0%)
Mar 2012
-
-$3.02M(-140.3%)
$3.68M(+29.8%)
DateAnnualQuarterlyTTM
Dec 2011
-$5.16M(-27.6%)
$7.49M(+282.6%)
$2.84M(+298.1%)
Sep 2011
-
$1.96M(+171.3%)
-$1.43M(+57.7%)
Jun 2011
-
-$2.74M(+29.0%)
-$3.39M(-424.0%)
Mar 2011
-
-$3.86M(-220.1%)
-$647.00K(-120.1%)
Dec 2010
-$4.05M(+25.4%)
$3.22M(+156.9%)
$3.22M(+109.5%)
Dec 2009
-$5.42M(-25.6%)
-
-
Dec 2008
-$4.32M(+87.5%)
-
-
Dec 2007
-$34.65M(-4.4%)
-$5.65M(+26.3%)
-$33.80M(+2.6%)
Sep 2007
-
-$7.67M(+38.4%)
-$34.69M(+4.6%)
Jun 2007
-
-$12.44M(-54.7%)
-$36.39M(-12.4%)
Mar 2007
-
-$8.04M(-22.8%)
-$32.38M(+2.5%)
Dec 2006
-$33.20M(+7.8%)
-$6.55M(+30.0%)
-$33.20M(+9.1%)
Sep 2006
-
-$9.36M(-10.9%)
-$36.54M(+4.1%)
Jun 2006
-
-$8.43M(+4.9%)
-$38.10M(+0.2%)
Mar 2006
-
-$8.86M(+10.3%)
-$38.18M(-6.0%)
Dec 2005
-$36.03M(-417.0%)
-$9.88M(+9.5%)
-$36.02M(-77.8%)
Sep 2005
-
-$10.92M(-28.3%)
-$20.26M(-210.7%)
Jun 2005
-
-$8.51M(-26.9%)
-$6.52M(-2505.9%)
Mar 2005
-
-$6.71M(-214.0%)
$271.00K(-97.6%)
Dec 2004
$11.37M(+480.5%)
$5.88M(+108.8%)
$11.37M(+87.8%)
Sep 2004
-
$2.82M(+263.8%)
$6.05M(+305.3%)
Jun 2004
-
-$1.72M(-139.2%)
$1.49M(-7.7%)
Mar 2004
-
$4.39M(+672.2%)
$1.62M(+134.2%)
Dec 2003
-$2.99M(-341.5%)
$568.00K(+132.6%)
-$4.73M(+42.9%)
Sep 2003
-
-$1.74M(-9.1%)
-$8.28M(-91.9%)
Jun 2003
-
-$1.60M(+18.5%)
-$4.31M(-288.9%)
Mar 2003
-
-$1.96M(+34.3%)
$2.28M(-74.1%)
Dec 2002
$1.24M(+165.6%)
-$2.98M(-234.1%)
$8.80M(+8529.4%)
Sep 2002
-
$2.22M(-55.5%)
$102.00K(-79.8%)
Jun 2002
-
$5.00M(+9.6%)
$504.00K(+124.4%)
Mar 2002
-
$4.56M(+139.0%)
-$2.06M(+34.6%)
Dec 2001
-$1.89M(+87.4%)
-$11.68M(-545.0%)
-$3.15M(+79.8%)
Sep 2001
-
$2.63M(+7.9%)
-$15.58M(-2.5%)
Jun 2001
-
$2.43M(-29.8%)
-$15.21M(-2.8%)
Mar 2001
-
$3.47M(+114.4%)
-$14.80M(+9.1%)
Dec 2000
-$14.99M(-158.8%)
-$24.11M(-903.6%)
-$16.28M(-407.6%)
Sep 2000
-
$3.00M(+5.6%)
-$3.21M(+29.0%)
Jun 2000
-
$2.84M(+43.4%)
-$4.52M(+28.4%)
Mar 2000
-
$1.98M(+118.0%)
-$6.32M(+9.7%)
Dec 1999
-$5.79M(+29.8%)
-$11.03M(-753.6%)
-$7.00M(+41.0%)
Sep 1999
-
$1.69M(+61.4%)
-$11.86M(-0.1%)
Jun 1999
-
$1.05M(-19.5%)
-$11.85M(-16.2%)
Mar 1999
-
$1.30M(+108.2%)
-$10.19M(+27.7%)
Dec 1998
-$8.25M(+0.6%)
-$15.89M(-1034.8%)
-$14.09M(-18.4%)
Sep 1998
-
$1.70M(-37.0%)
-$11.90M(+4.0%)
Jun 1998
-
$2.70M(+203.8%)
-$12.40M(+10.1%)
Mar 1998
-
-$2.60M(+81.0%)
-$13.80M(-51.6%)
Dec 1997
-$8.30M(-2.5%)
-$13.70M(-1241.7%)
-$9.10M(-12.3%)
Sep 1997
-
$1.20M(-7.7%)
-$8.10M(+5.8%)
Jun 1997
-
$1.30M(-38.1%)
-$8.60M(+4.4%)
Mar 1997
-
$2.10M(+116.5%)
-$9.00M(+25.0%)
Dec 1996
-$8.10M
-$12.70M(-1914.3%)
-$12.00M(-1814.3%)
Sep 1996
-
$700.00K(-22.2%)
$700.00K(>+9900.0%)
Jun 1996
-
$900.00K(+200.0%)
$0.00(+100.0%)
Mar 1996
-
-$900.00K
-$900.00K

FAQ

  • What is Avadel Pharmaceuticals plc annual EBITDA?
  • What is the all-time high annual EBITDA for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc annual EBITDA year-on-year change?
  • What is Avadel Pharmaceuticals plc quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc quarterly EBITDA year-on-year change?
  • What is Avadel Pharmaceuticals plc TTM EBITDA?
  • What is the all-time high TTM EBITDA for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc TTM EBITDA year-on-year change?

What is Avadel Pharmaceuticals plc annual EBITDA?

The current annual EBITDA of AVDL is -$35.57M

What is the all-time high annual EBITDA for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high annual EBITDA is $98.59M

What is Avadel Pharmaceuticals plc annual EBITDA year-on-year change?

Over the past year, AVDL annual EBITDA has changed by +$113.56M (+76.15%)

What is Avadel Pharmaceuticals plc quarterly EBITDA?

The current quarterly EBITDA of AVDL is $3.05M

What is the all-time high quarterly EBITDA for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high quarterly EBITDA is $33.96M

What is Avadel Pharmaceuticals plc quarterly EBITDA year-on-year change?

Over the past year, AVDL quarterly EBITDA has changed by +$2.34M (+331.07%)

What is Avadel Pharmaceuticals plc TTM EBITDA?

The current TTM EBITDA of AVDL is $8.20M

What is the all-time high TTM EBITDA for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high TTM EBITDA is $115.08M

What is Avadel Pharmaceuticals plc TTM EBITDA year-on-year change?

Over the past year, AVDL TTM EBITDA has changed by +$70.23M (+113.22%)
On this page